CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Manitoba
About this trial
The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care will lead to a reduction in composite emergency department (ED) visits and/or hospitalizations/or increase the perceived safety of virtual care among patients and providers.
Eligibility criteria
Qualifiers
>18 years of age
Patient or primary caregiver can read and speak English
Patient or patients substitute decision maker is able to provide informed consent
Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e. weight, BP, etc.)
Disqualifiers
Inability of self or caregiver assisted self-monitoring using VIEWER
Trial design
Treatments tested in this trial
- VIEWER virtual care platform
Treatment groups
340 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov